Cardiac autonomic neuropathy (CAN) is frequent in infraclinical stages. Its
prognostic Value has been demonstrated. Cardiac autonomic neuropathy induc
es different functional cardiac changes, especially a reduction in left ven
tricular contractility and changes in ventricular repolarisation. It is als
o associated with changes in the daily variations in blood pressure. The as
sociation of CAN and silent myocardial ischaemia significantly worsens the
prognosis.
The investigation of CAN in the greatest number of diabetic patients is the
refore justified. The study of heart rate Variations during deep respiratio
n, active orthostatism or Valsalva manoeuvre, is still the reference. This
method is simple, reproductible and may be carried out in the clinical sett
ing in 10 to 15 minutes. The results must be strictly interpreted with rigo
ur with respect to age. Orthostatic hypotension is a late sign of sympathet
ic nervous system disease. Spectral analysis of blood pressure Variations o
n orthostatism or the study of cutaneous blood flow during activating the s
ympathetic system tests of greater sensitivity, should be developed.
The demonstration of infraclinical CAN should lead to the careful use of dr
ugs which may induce orthostatic hypotension and certain antiarrhythmics, t
o search for disorders of ventricular repolarisation and for silent myocard
ial ischaemia in diabetics with several risk factors.